Breakthrough platform utilizes 3D digital visualization, state-of-the-art software and augmentation capabilities which are unmatched by any competitor digital microscope platform. GOLETA, Calif., Sept. 16, 2020 /PRNewswire/ -- True Digital Surgery (TDS) and Aesculap, Inc....
Spine Innovator Building ‘A-Team’ of Spinal Device Sales Professionals KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Camber Spine, a leading innovator in spine and medical technologies, has named Max Painter its new Global Vice...
LONDON, Sept. 15, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces it has teamed up with Avail Medsystems (Palo Alto, CA) to provide remote, real-time collaboration services to...
CoreLink's new OLIF offering includes approach-specific instruments for lower lumbar spine anterolateral access and fusion. ST. LOUIS, Sept. 15, 2020 /PRNewswire/ -- CoreLink, LLC, a leading designer and manufacturer of spinal implant systems, today...
NovoPedics, Inc. announced today that MeniscoFix™, a total meniscus replacement device currently under development, has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration. PRINCETON, N.J. (PRWEB) SEPTEMBER 14,...
PETOSKEY, Mich.--(BUSINESS WIRE)--BioStar Capital, a value-add investment firm focused on transformational medical device technologies that serve unmet patient needs in cardiovascular and orthopedic medicine, today announced that Mark Toland, former...
15.09.2020 MEDICA 2020 and COMPAMED 2020, the world-leading information and communication platforms for the medical technology industry and supplier industry for the medical technology industry, will take place entirely online from...
Limited impact of the COVID-19 pandemic on the recurring operating result Upturn in activity beginning June 2020 Resumption of surgical operations seen in the 3rd quarter of 2020 Implanet is holding...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the appointment of Paul Gonsalves as President of the Orthofix Global...
Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L antibody, in development for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases Senior management team with extensive drug development and...